New Diagnostic Test Uses Color-Changing Nanoparticles to Identify Dangerous Bacteria

A team of researchers has developed a new diagnostic test that uses color-changing nanoparticles to rapidly distinguish between different strains of the bacterium Staphylococcus aureus.

Test Design and Function

The test was developed by researchers at Australia's Royal Melbourne Institute of Technology (RMIT) in collaboration with international partners. It uses gold nanoparticles combined with short DNA molecular binders.

When these components interact with bacterial strains, they produce distinct color patterns or "fingerprints" unique to each strain.

According to the study published in the journal Small, the test is designed to identify strains that are likely to be highly virulent or antibiotic-resistant.

Background and Need

Staphylococcus aureus, commonly known as golden staph, is a major human pathogen. The researchers note it is responsible for over a million infection-related deaths globally each year.

Current standard methods for identifying bacterial strains and their antibiotic resistance profiles, such as culture-based tests or PCR, can require significant time and specialized laboratory infrastructure.

Reported Performance and Potential

In laboratory testing, the researchers reported that the sensor produced comparable strain fingerprints in simulated wound fluid. The test accurately distinguished between different staph strains and, in some cases, showed stronger and faster responses.

RMIT Professor Rajesh Ramanathan, a co-lead author of the study, stated that the rapid test offers an early signal about the potential aggressiveness of a staph infection. He noted that the technique could be modified to identify dangerous strains of other pathogens beyond Staphylococcus aureus.

The researchers described the test as a potential low-cost alternative to traditional diagnostic methods.

Potential Application

The development team stated that the fingerprint test could allow clinicians to recognize highly virulent or antibiotic-resistant bacterial strains more quickly. This faster identification could, in turn, guide more timely treatment decisions.